ACS Publications. Most Trusted. Most Cited. Most Read
My Activity

Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor

Cite this: J. Med. Chem. 1993, 36, 20, 3032–3034
Publication Date (Print):October 1, 1993
    ACS Legacy Archive

    Article Views





    Other access options
    Supporting Info (1)»

    Note: In lieu of an abstract, this is the article's first page.

    Free first page

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.


    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

    Supporting Information

    Terms & Conditions

    Electronic Supporting Information files are available without a subscription to ACS Web Editions. The American Chemical Society holds a copyright ownership interest in any copyrightable Supporting Information. Files available from the ACS website may be downloaded for personal use only. Users are not otherwise permitted to reproduce, republish, redistribute, or sell any Supporting Information from the ACS website, either in whole or in part, in either machine-readable form or any other form without permission from the American Chemical Society. For permission to reproduce, republish and redistribute this material, requesters must process their own requests via the RightsLink permission system. Information about how to use the RightsLink permission system can be found at

    Cited By

    This article is cited by 258 publications.

    1. Ganesh A. Thakur, Shama Bajaj, Carol Paronis, Yan Peng, Anna L. Bowman, Lawrence S. Barak, Marc G. Caron, Demon Parrish, Jeffrey R. Deschamps, and Alexandros Makriyannis . Novel Adamantyl Cannabinoids as CB1 Receptor Probes. Journal of Medicinal Chemistry 2013, 56 (10) , 3904-3921.
    2. Sharon M. Sagnella, Charlotte E. Conn, Irena Krodkiewska, Minoo Moghaddam, John M. Seddon and Calum J. Drummond . Ordered Nanostructured Amphiphile Self-Assembly Materials from Endogenous Nonionic Unsaturated Monoethanolamide Lipids in Water. Langmuir 2010, 26 (5) , 3084-3094.
    3. John Williams,, JodiAnne Wood,, Lakshmipathi Pandarinathan,, David A. Karanian,, Ben A. Bahr,, Paul Vouros, and, Alexandros Makriyannis. Quantitative Method for the Profiling of the Endocannabinoid Metabolome by LC-Atmospheric Pressure Chemical Ionization-MS. Analytical Chemistry 2007, 79 (15) , 5582-5593.
    4. Didier M. Lambert and, Christopher J. Fowler. The Endocannabinoid System: Drug Targets, Lead Compounds, and Potential Therapeutic Applications. Journal of Medicinal Chemistry 2005, 48 (16) , 5059-5087.
    5. Judy Barnett-Norris,, Dow P. Hurst,, Diane L. Lynch,, Frank Guarnieri,, Alex Makriyannis, and, Patricia H. Reggio. Conformational Memories and the Endocannabinoid Binding Site at the Cannabinoid CB1 Receptor. Journal of Medicinal Chemistry 2002, 45 (17) , 3649-3659.
    6. Edward W. Ng,, Mie Mie Aung,, Mary E. Abood,, Billy R. Martin, and, Raj K. Razdan. Unique Analogues of Anandamide:  Arachidonyl Ethers and Carbamates and Norarachidonyl Carbamates and Ureas. Journal of Medicinal Chemistry 1999, 42 (11) , 1975-1981.
    7. Wensheng Lang,, Ce Qin,, Sonyuan Lin,, Atmaram D. Khanolkar,, Andreas Goutopoulos,, Pusheng Fan,, Khaled Abouzid,, Zhaoxing Meng,, Diane Biegel, and, Alexandros Makriyannis. Substrate Specificity and Stereoselectivity of Rat Brain Microsomal Anandamide Amidohydrolase. Journal of Medicinal Chemistry 1999, 42 (5) , 896-902.
    8. Sonyuan Lin,, Atmaram D. Khanolkar,, Pusheng Fan,, Andreas Goutopoulos,, Ce Qin,, Demetris Papahadjis, and, Alexandros Makriyannis. Novel Analogues of Arachidonylethanolamide (Anandamide):  Affinities for the CB1 and CB2 Cannabinoid Receptors and Metabolic Stability. Journal of Medicinal Chemistry 1998, 41 (27) , 5353-5361.
    9. Weida Tong,, Elizabeth R. Collantes, and, William J. Welsh, , Barbara A. Berglund and, Allyn C. Howlett. Derivation of a Pharmacophore Model for Anandamide Using Constrained Conformational Searching and Comparative Molecular Field Analysis. Journal of Medicinal Chemistry 1998, 41 (22) , 4207-4215.
    10. William J. Ryan,, W. Kenneth Banner,, Jenny L. Wiley,, Billy R. Martin, and, Raj K. Razdan. Potent Anandamide Analogs:  The Effect of Changing the Length and Branching of the End Pentyl Chain. Journal of Medicinal Chemistry 1997, 40 (22) , 3617-3625.
    11. Tzviel Sheskin,, Lumir Hanuš,, Joram Slager,, Zvi Vogel, and, Raphael Mechoulam. Structural Requirements for Binding of Anandamide-Type Compounds to the Brain Cannabinoid Receptor. Journal of Medicinal Chemistry 1997, 40 (5) , 659-667.
    12. Brian F. Thomas,, Irma B. Adams,, S. Wayne Mascarella,, Billy R. Martin, and, Raj K. Razdan. Structure−Activity Analysis of Anandamide Analogs:  Relationship to a Cannabinoid Pharmacophore. Journal of Medicinal Chemistry 1996, 39 (2) , 471-479.
    13. A Pařízek, J Suchopár, Z Laštůvka, M Alblová, M Hill, M Dušková. The Endocannabinoid System and Its Relationship to Human Reproduction. Physiological Research 2023, , S365-S380.
    14. Natalya M. Kogan, Dilorom Begmatova, Liudmila Vinnikova, Sergey Malitsky, Maxim Itkin, Eyal Sharon, Artem Klinov, Jonathan Gorelick, Igor Koman, Zvi Vogel, Raphael Mechoulam, Albert Pinhasov. Endocannabinoid basis of personality—Insights from animal model of social behavior. Frontiers in Pharmacology 2023, 14
    15. Lan Jiang, Xiaochun Gai, Ya Ni, Ting Qiang, Yingying Zhang, Xiao Kang, Ke Xiong, Jinyu Wang. Folic acid protects against tuberculosis-drug-induced liver injury in rats and its potential mechanism by metabolomics. The Journal of Nutritional Biochemistry 2023, 112 , 109214.
    16. Raphael Mechoulam. A Delightful Trip Along the Pathway of Cannabinoid and Endocannabinoid Chemistry and Pharmacology. Annual Review of Pharmacology and Toxicology 2023, 63 (1) , 1-13.
    17. Isabel Baenas, Romina Miranda-Olivos, Roser Granero, Neus Solé-Morata, Isabel Sánchez, Antoni Pastor, Amparo del Pino-Gutiérrez, Ester Codina, Francisco J. Tinahones, José A. Fernández-Formoso, Núria Vilarrasa, Fernando Guerrero-Pérez, Rafael Lopez-Urdiales, Núria Virgili, Carles Soriano-Mas, Susana Jiménez-Murcia, Rafael de la Torre, Fernando Fernández-Aranda. Association of anandamide and 2-arachidonoylglycerol concentrations with clinical features and body mass index in eating disorders and obesity. European Psychiatry 2023, 66 (1)
    18. Jyoti Sihag, Vincenzo Di Marzo. (Wh)olistic (E)ndocannabinoidome-Microbiome-Axis Modulation through (N)utrition (WHEN) to Curb Obesity and Related Disorders. Lipids in Health and Disease 2022, 21 (1)
    19. Judah Glogauer, Jonathan Blay. Cannabinoids, their cellular receptors, and effects on the invasive phenotype of carcinoma and metastasis. Cancer Reports 2022, 5 (2)
    20. Michael H. Myoga, Wade G. Regehr. Cannabinoids and Synaptic Transmission in the Cerebellum. 2022, 1005-1023.
    21. Sukanya Arul Prakash, Ravi Kanth Kamlekar. Function and therapeutic potential of N-acyl amino acids. Chemistry and Physics of Lipids 2021, 239 , 105114.
    22. Cristina Sempio, Jelena Klawitter, Matthew Jackson, Francesca Freni, Ryan Shillingburg, Kent Hutchison, L. Cinnamon Bidwell, Uwe Christians, Jost Klawitter. Analysis of 14 endocannabinoids and endocannabinoid congeners in human plasma using column switching high-performance atmospheric pressure chemical ionization liquid chromatography–mass spectrometry. Analytical and Bioanalytical Chemistry 2021, 413 (12) , 3381-3392.
    23. Xin Chien Lee, Evelyn Werner, Marco Falasca. Molecular Mechanism of Autophagy and Its Regulation by Cannabinoids in Cancer. Cancers 2021, 13 (6) , 1211.
    24. Tristyn L. Clarke, Rachael L. Johnson, Jonathan J. Simone, Robert L. Carlone. The Endocannabinoid System and Invertebrate Neurodevelopment and Regeneration. International Journal of Molecular Sciences 2021, 22 (4) , 2103.
    25. Engin YÜCEL, Zühal AKTUNA, İsmail Semih KESKİL. Effects of endocannabinoids in pentylenetetrazole induced seizures in mice. Acta Medica Alanya 2020, 4 (3) , 209-215.
    26. , , Aruna Kilaru, Kent D. Chapman. The endocannabinoid system. Essays in Biochemistry 2020, 64 (3) , 485-499.
    27. Lumír Ondřej Hanuš, Yotam Hod. Terpenes/Terpenoids in Cannabis: Are They Important?. Medical Cannabis and Cannabinoids 2020, 3 (1) , 25-60.
    28. Carla Ferreira, Catarina Almeida, Sandra Tenreiro, Alexandre Quintas. Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson’s Disease. Life 2020, 10 (6) , 86.
    29. Pal Pacher, Natalya M. Kogan, Raphael Mechoulam. Beyond THC and Endocannabinoids. Annual Review of Pharmacology and Toxicology 2020, 60 (1) , 637-659.
    30. Mariah M. Wu, Xinwen Zhang, Melissa J. Asher, Stanley A. Thayer. Druggable targets of the endocannabinoid system: Implications for the treatment of HIV-associated neurocognitive disorder. Brain Research 2019, 1724 , 146467.
    31. Jyoti Sihag, Peter J.H. Jones. Dietary fatty acid profile influences circulating and tissue fatty acid ethanolamide concentrations in a tissue-specific manner in male Syrian hamsters. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2019, 1864 (11) , 1563-1579.
    32. Luis Apaza T., Victor Tena Pérez, Andreea Madalina Serban, Matías J. Alonso Navarro, Angel Rumbero. Alkamides from Tropaeolum tuberosum inhibit inflammatory response induced by TNF–α and NF–κB. Journal of Ethnopharmacology 2019, 235 , 199-205.
    33. Burkhard Hinz, Robert Ramer. Anti‐tumour actions of cannabinoids. British Journal of Pharmacology 2019, 176 (10) , 1384-1394.
    34. Lauren N. Carnevale, Aditi Das. Novel Anti-inflammatory and Vasodilatory ω-3 Endocannabinoid Epoxide Regioisomers. 2019, 219-232.
    35. Nahed Alharthi, Peter Christensen, Wafa Hourani, Catherine Ortori, David A. Barrett, Andrew J. Bennett, Victoria Chapman, Stephen P.H. Alexander. n−3 polyunsaturated N-acylethanolamines are CB2 cannabinoid receptor-preferring endocannabinoids. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2018, 1863 (11) , 1433-1440.
    36. Janos Paloczi, Zoltan V. Varga, George Hasko, Pal Pacher. Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation. Antioxidants & Redox Signaling 2018, 29 (1) , 75-108.
    37. Rico Schwarz, Robert Ramer, Burkhard Hinz. Targeting the endocannabinoid system as a potential anticancer approach. Drug Metabolism Reviews 2018, 50 (1) , 26-53.
    38. Jyoti Sihag, Peter J. H. Jones. Dietary fatty acid composition impacts plasma fatty acid ethanolamide levels and body composition in golden Syrian hamsters. Food & Function 2018, 9 (6) , 3351-3362.
    39. Vadim Shevyrin, Vladimir Melkozerov, Gregory W. Endres, Yuri Shafran, Yuri Morzherin. On a New Cannabinoid Classification System: A Sight on the Illegal Market of Novel Psychoactive Substances. Cannabis and Cannabinoid Research 2016, 1 (1) , 186-194.
    40. Vino Daniel. Central Analgesic Activity. 2016, 1785-1874.
    41. Lenita Lindgren, Sandra Gouveia-Figueira, Malin L. Nording, Christopher J. Fowler. Endocannabinoids and related lipids in blood plasma following touch massage: a randomised, crossover study. BMC Research Notes 2015, 8 (1)
    42. Ming Qi, Maria Morena, Haley A. Vecchiarelli, Matthew N. Hill, David C. Schriemer. A robust capillary liquid chromatography/tandem mass spectrometry method for quantitation of neuromodulatory endocannabinoids. Rapid Communications in Mass Spectrometry 2015, 29 (20) , 1889-1897.
    43. Luis A. Natividad, Paola Maccioni, Loren H. Parsons, Giancarlo Colombo. Cannabinoid-Alcohol Interactions. 2015, 363-391.
    44. Roger G. Pertwee. Endocannabinoids and Their Pharmacological Actions. 2015, 1-37.
    45. Bandana Chakravarti, Janani Ravi, Ramesh K. Ganju. Cannabinoids as therapeutic agents in cancer: current status and future implications. Oncotarget 2014, 5 (15) , 5852-5872.
    46. Filomena Fezza, Mauro Maccarrone. Endocannabinoid biochemistry: What do we know after 50 years?. 2014, 53-94.
    47. Karen Kleberg, Helle A. Hassing, Harald S. Hansen. Classical endocannabinoid‐like compounds and their regulation by nutrients. BioFactors 2014, 40 (4) , 363-372.
    48. Vino Daniel. Central Analgesic Activity. 2014, 1-104.
    49. J.D. Figueroa, K. Cordero, M. Serrano-Illan, A. Almeyda, K. Baldeosingh, F.G. Almaguel, M. De Leon. Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury. Neuroscience 2013, 255 , 1-18.
    50. Hsiu-Wen Chan, Natalie C McKirdy, Hassendrini N Peiris, Gregory E Rice, Murray D Mitchell. The role of endocannabinoids in pregnancy. REPRODUCTION 2013, 146 (3) , R101-R109.
    51. David Balgoma, Antonio Checa, Daniel García Sar, Stuart Snowden, Craig E. Wheelock. Quantitative metabolic profiling of lipid mediators. Molecular Nutrition & Food Research 2013, 57 (8) , 1359-1377.
    52. Jahan Marcu, Linda Console-Bram, Mary E. Abood. Current Cannabinoid Receptor Nomenclature and Pharmacological Principles. 2013, 25-54.
    53. Michael H. Myoga, Wade G. Regehr. Cannabinoids and Synaptic Transmission in the Cerebellum. 2013, 927-946.
    54. Tsukasa Ishida, Shin Nishiumi, Toshihito Tanahashi, Akifumi Yamasaki, Asahi Yamazaki, Takahiro Akashi, Ikuya Miki, Yasuyuki Kondo, Jun Inoue, Shoji Kawauchi, Takeshi Azuma, Masaru Yoshida, Shigeto Mizuno. Linoleoyl ethanolamide reduces lipopolysaccharide-induced inflammation in macrophages and ameliorates 2,4-dinitrofluorobenzene-induced contact dermatitis in mice. European Journal of Pharmacology 2013, 699 (1-3) , 6-13.
    55. Hee-Yong Kim, Arthur A. Spector. Synaptamide, endocannabinoid-like derivative of docosahexaenoic acid with cannabinoid-independent function. Prostaglandins, Leukotrienes and Essential Fatty Acids 2013, 88 (1) , 121-125.
    56. Roberta Ottria, Silvana Casati, Pierangela Ciuffreda. 1 H, 13 C and 15 N NMR assignments for N ‐ and O ‐acylethanolamines, important family of naturally occurring bioactive lipid mediators. Magnetic Resonance in Chemistry 2012, 50 (12) , 823-828.
    57. Linda Console-Bram, Jahan Marcu, Mary E. Abood. Cannabinoid receptors: nomenclature and pharmacological principles. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2012, 38 (1) , 4-15.
    58. CJ Fowler. Monoacylglycerol lipase – a target for drug development?. British Journal of Pharmacology 2012, 166 (5) , 1568-1585.
    59. Matthew J. Pava, John J. Woodward. A review of the interactions between alcohol and the endocannabinoid system: Implications for alcohol dependence and future directions for research. Alcohol 2012, 46 (3) , 185-204.
    60. Saoirse E O’Sullivan, Patrick J Kendall, David A Kendall. Endocannabinoids and the cardiovascular response to stress. Journal of Psychopharmacology 2012, 26 (1) , 71-82.
    61. George Kokotos. Endocannabinoids. 2012, 245-264.
    62. Nimish Sidhpura, Loren H. Parsons. Endocannabinoid-mediated synaptic plasticity and addiction-related behavior. Neuropharmacology 2011, 61 (7) , 1070-1087.
    63. Antonia Serrano, Loren H. Parsons. Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors. Pharmacology & Therapeutics 2011, 132 (3) , 215-241.
    64. Torbjörn U. C. Järbe. Perceptual Drug Discriminative Aspects of the Endocannabinoid Signaling System in Animals And Man. 2011, 241-285.
    65. J. Donovan, D. Grundy. The differential effect of CB1 receptors on the discharge of afferent and efferent fibres supplying the rat jejunum. Neurogastroenterology & Motility 2011, 23 (6) , 567-e209.
    66. Michael R. Ruggieri. Cannabinoids: Potential Targets for Bladder Dysfunction. 2011, 425-451.
    67. Natsuo Ueda, Kazuhito Tsuboi, Toru Uyama. Enzymological studies on the biosynthesis of N-acylethanolamines. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2010, 1801 (12) , 1274-1285.
    68. Eduardo Tibiriça. The multiple functions of the endocannabinoid system: a focus on the regulation of food intake. Diabetology & Metabolic Syndrome 2010, 2 (1)
    69. Cyrine Ezzili, Katerina Otrubova, Dale L. Boger. Fatty acid amide signaling molecules. Bioorganic & Medicinal Chemistry Letters 2010, 20 (20) , 5959-5968.
    70. Natsuo Ueda, Kazuhito Tsuboi, Toru Uyama. N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA). Progress in Lipid Research 2010, 49 (4) , 299-315.
    71. Harald S. Hansen. Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain. Experimental Neurology 2010, 224 (1) , 48-55.
    72. Dimitris Anagnostopoulos, Carmelina Rakiec, Jodi Wood, Lakshmipathi Pandarinathan, Nikolai Zvonok, Alexandros Makriyannis, Athanasia Siafaka-Kapadai. Identification of Endocannabinoids and Related N-Acylethanolamines in Tetrahymena. A New Class of Compounds for Tetrahymena. Protist 2010, 161 (3) , 452-465.
    73. Michelle R. Hoot, Laura J. Sim-Selley, Justin L. Poklis, Rehab A. Abdullah, Krista L. Scoggins, Dana E. Selley, William L. Dewey. Chronic constriction injury reduces cannabinoid receptor 1 activity in the rostral anterior cingulate cortex of mice. Brain Research 2010, 1339 , 18-25.
    74. Matthew W Buczynski, Loren H Parsons. Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls. British Journal of Pharmacology 2010, 160 (3) , 423-442.
    75. Jeong Jun Han, Jae Kwang Song, Joon Shick Rhee, Suk Hoo Yoon. Biotechnological Uses of Phospholipids. 2010, 277-298.
    76. Dana Turcotte, Josée-Anne Le Dorze, Farid Esfahani, Emma Frost, Andrew Gomori, Mike Namaka. Examining the roles of cannabinoids in pain and other therapeutic indications: a review. Expert Opinion on Pharmacotherapy 2010, 11 (1) , 17-31.
    77. Saveria Aquila, Carmela Guido, Chiara Laezza, Antonietta Santoro, Vincenzo Pezzi, Salvatore Panza, Sebastiano Andò, Maurizio Bifulco. A new role of anandamide in human sperm: Focus on metabolism. Journal of Cellular Physiology 2009, 221 (1) , 147-153.
    78. Giuseppe Astarita, Daniele Piomelli. Lipidomic analysis of endocannabinoid metabolism in biological samples. Journal of Chromatography B 2009, 877 (26) , 2755-2767.
    79. Philip J. Kingsley, Lawrence J. Marnett. Analysis of endocannabinoids, their congeners and COX-2 metabolites. Journal of Chromatography B 2009, 877 (26) , 2746-2754.
    80. María Martínez de Ubago, Inmaculada García-Oya, Antonio Pérez-Pérez, Alberto Canfrán-Duque, Rocio Quintana-Portillo, Fernando Rodríguez de Fonseca, Carmen González-Yanes, Víctor Sánchez-Margalet. Oleoylethanolamide, a natural ligand for PPAR-alpha, inhibits insulin receptor signalling in HTC rat hepatoma cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2009, 1791 (8) , 740-745.
    81. Michiel G.J. Balvers, Kitty C.M. Verhoeckx, Renger F. Witkamp. Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography–tandem mass spectrometry. Journal of Chromatography B 2009, 877 (14-15) , 1583-1590.
    82. Lumír Ondřej Hanuš. Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids. Medicinal Research Reviews 2009, 29 (2) , 213-271.
    83. Tiziana Bisogno, Fabiana Piscitelli, Vincenzo Di Marzo. Lipidomic methodologies applicable to the study of endocannabinoids and related compounds: Endocannabinoidomics. European Journal of Lipid Science and Technology 2009, 111 (1) , 53-63.
    84. S. Petrosino, V. Di Marzo. Anandamide and Other Acylethanolamides. 2009, 75-98.
    85. V. Kiran Vemuri, Alexandros Makriyannis. Endocannabinoids and Their Synthetic Analogs. 2009, 21-48.
    86. Mary E. Abood. Molecular Biology of Cannabinoid Receptors: Mutational Analyses of the CB Receptors. 2009, 203-234.
    87. Stephen P. H. Alexander, David A. Kendall. The Life Cycle of the Endocannabinoids: Formation and Inactivation. 2009, 3-35.
    88. Giuseppe Astarita, Jennifer Geaga, Faizy Ahmed, Daniele Piomelli. Chapter 4 Targeted Lipidomics as a Tool to Investigate Endocannabinoid Function. 2009, 35-55.
    89. Masanobu Kano, Takako Ohno-Shosaku, Yuki Hashimotodani, Motokazu Uchigashima, Masahiko Watanabe. Endocannabinoid-Mediated Control of Synaptic Transmission. Physiological Reviews 2009, 89 (1) , 309-380.
    90. Jing Chen, Kalpana S. Paudel, Andrei V. Derbenev, Bret N. Smith, Audra L. Stinchcomb. Simultaneous Quantification of Anandamide and Other Endocannabinoids in Dorsal Vagal Complex of Rat Brainstem by LC–MS. Chromatographia 2009, 69 (1-2) , 1-7.
    91. Jing Chen Xiao, James P. Jewell, Linus S. Lin, William K. Hagmann, Tung M. Fong, Chun-Pyn Shen. Similar in vitro pharmacology of human cannabinoid CB1 receptor variants expressed in CHO cells. Brain Research 2008, 1238 , 36-43.
    92. Artur Dembiński, Zygmunt Warzecha, Piotr Ceranowicz, Anna M. Warzecha, Wiesław W. Pawlik, Marcin Dembiński, Kazimierz Rembiasz, Paweł Sendur, Beata Kuśnierz-Cabala, Romana Tomaszewska, Eve Chowaniec, Peter C. Konturek. Dual, time-dependent deleterious and protective effect of anandamide on the course of cerulein-induced acute pancreatitis. Role of sensory nerves. European Journal of Pharmacology 2008, 591 (1-3) , 284-292.
    93. Eric Horne, Nephi Stella. The ins and outs of endocannabinoid signaling in healthy and diseased brain. Future Lipidology 2008, 3 (4) , 435-452.
    94. Giulio G. Muccioli, Nephi Stella. An optimized GC–MS method detects nanomolar amounts of anandamide in mouse brain. Analytical Biochemistry 2008, 373 (2) , 220-228.
    95. B. S. Basavarajappa, R. Yalamanchili, T. B. Cooper, B. L. Hungund. The Endocannabinoid System. 2008, 343-384.
    96. Heather B. Bradshaw. Other Cannabimimetic Lipid Signaling Molecules. 2008, 47-58.
    97. A M Miller, N Stella. CB 2 receptor‐mediated migration of immune cells: it can go either way. British Journal of Pharmacology 2008, 153 (2) , 299-308.
    98. Georg Juckel, Patrik Roser, Thomas Nadulski, Andreas M. Stadelmann, Jürgen Gallinat. Acute effects of Δ9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity. Schizophrenia Research 2007, 97 (1-3) , 109-117.
    99. C J Fowler. The contribution of cyclooxygenase‐2 to endocannabinoid metabolism and action. British Journal of Pharmacology 2007, 152 (5) , 594-601.
    100. Susanna M. Saario, Jarmo T. Laitinen. Therapeutic Potential of Endocannabinoid‐Hydrolysing Enzyme Inhibitors. Basic & Clinical Pharmacology & Toxicology 2007, 101 (5) , 287-293.
    Load more citations

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Your Mendeley pairing has expired. Please reconnect